$52.5 million investment hug for Glen Tullman’s company
March 16th, 2017
Glen Tullman’s Chicago health-care startup company, Livongo Health, has raised an amazing $52.5 million from investors.
“This new funding will allow Livongo to accelerate our diabetes capabilities, expand to additional chronic conditions, and enter international markets,” the former CEO of Allscripts said in an email. “I truly believe that we’re at the beginning of a revolution in healthcare.”
Livongo uses new technology to help patients better manage diabetes and other chronic conditions.
Leading investors are General Catalyst, which previously invested in Livongo, and Kinnevik, a Swedish investment company.
Hemant Taneja, managing director at General Catalyst, calls Livongo “one of the fastest growing” companies in its portfolio. “We are excited to see Livongo expand their service to offer comprehensive support for their members’ chronic needs beyond diabetes,” he said in a press release.
Tullman, like his entrepreneurial brother Howard Tullman, is involved in numerous businesses and ventures in Chicago. Glen serves as managing partner at 7wire Ventures, which funds companies focused on health-care, education and energy. He’s been on the board of ArgoTea and co-owns Ignite Glass Studios.
His focus in recent years has been on health care and Livongo, which is based in California but has offices in Chicago. It’s work that’s been paying off.